John Jaeger

John is a managing director within Deloitte Consulting and serves as a leader within Deloitte’s Value, Access, and Pricing Strategy practice. For more than 18 years, Jaeger has advised life science clients on commercial strategy focused on market access, biosimilar entry, reimbursement, pricing, and life cycle management. His primary area of focus is on assisting life science customers to optimize patient access and affordability, while developing sustainable commercial and pricing models.